258 related articles for article (PubMed ID: 15621307)
1. Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets.
Breathnach CC; Soboll G; Suresh M; Lunn DP
Vet Immunol Immunopathol; 2005 Feb; 103(3-4):207-15. PubMed ID: 15621307
[TBL] [Abstract][Full Text] [Related]
2. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1.
Paillot R; Daly JM; Juillard V; Minke JM; Hannant D; Kydd JH
Vaccine; 2005 Aug; 23(36):4541-51. PubMed ID: 15913852
[TBL] [Abstract][Full Text] [Related]
3. Cytokine responses to EHV-1 infection in immune and non-immune ponies.
Coombs DK; Patton T; Kohler AK; Soboll G; Breathnach C; Townsend HG; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):109-16. PubMed ID: 16473413
[TBL] [Abstract][Full Text] [Related]
4. Frequency and phenotype of EHV-1 specific, IFN-gamma synthesising lymphocytes in ponies: the effects of age, pregnancy and infection.
Paillot R; Daly JM; Luce R; Montesso F; Davis-Poynter N; Hannant D; Kydd JH
Dev Comp Immunol; 2007; 31(2):202-14. PubMed ID: 16824599
[TBL] [Abstract][Full Text] [Related]
5. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
Platt R; Sponseller BA; Chiang YW; Roth JA
Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.
Paillot R; Ellis SA; Daly JM; Audonnet JC; Minke JM; Davis-Poynter N; Hannant D; Kydd JH
Vaccine; 2006 Mar; 24(10):1490-500. PubMed ID: 16269205
[TBL] [Abstract][Full Text] [Related]
7. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
[TBL] [Abstract][Full Text] [Related]
8. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract.
Breathnach CC; Yeargan MR; Timoney JF; Allen GP
Vet Immunol Immunopathol; 2006 May; 111(1-2):117-25. PubMed ID: 16472871
[TBL] [Abstract][Full Text] [Related]
9. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
[TBL] [Abstract][Full Text] [Related]
10. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
11. Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-α induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains.
Wagner B; Wimer C; Freer H; Osterrieder N; Erb HN
Vet Immunol Immunopathol; 2011 Sep; 143(1-2):116-24. PubMed ID: 21764140
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte responses to virus and mitogen in ponies during experimental infection with equine herpesvirus 1.
Dutta SK; Myrup A; Bumgardner MK
Am J Vet Res; 1980 Dec; 41(12):2066-8. PubMed ID: 6259978
[TBL] [Abstract][Full Text] [Related]
13. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
Fitzpatrick DR; Studdert MJ
Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
[TBL] [Abstract][Full Text] [Related]
14. Immunity to equine herpesvirus type 1 (rhinopneumonitis): in vitro lymphocyte response.
Wilks CR; Coggins L
Am J Vet Res; 1976 May; 37(5):486-92. PubMed ID: 179451
[TBL] [Abstract][Full Text] [Related]
15. Characterization of monoclonal antibodies to equine interleukin-10 and detection of T regulatory 1 cells in horses.
Wagner B; Hillegas JM; Brinker DR; Horohov DW; Antczak DF
Vet Immunol Immunopathol; 2008 Mar; 122(1-2):57-64. PubMed ID: 18061278
[TBL] [Abstract][Full Text] [Related]
16. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
[TBL] [Abstract][Full Text] [Related]
17. Immune response against equine gammaherpesvirus in Icelandic horses.
Svansson V; Roelse M; Olafsdóttir G; Thorsteinsdóttir L; Torfason EG; Torsteinsdóttir S
Vet Microbiol; 2009 Jun; 137(3-4):363-8. PubMed ID: 19217222
[TBL] [Abstract][Full Text] [Related]
18. In vitro cytotoxicity of serum and peripheral blood leukocytes for equine herpesvirus type 1-infected target cells.
Wilks CR
Am J Vet Res; 1977 Jan; 38(1):117-21. PubMed ID: 189645
[TBL] [Abstract][Full Text] [Related]
19. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares.
Kydd JH; Wattrang E; Hannant D
Vet Immunol Immunopathol; 2003 Dec; 96(3-4):207-17. PubMed ID: 14592733
[TBL] [Abstract][Full Text] [Related]
20. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
